STAG2 and glioblastoma: Somatic mutations of the SA2 gene and loss of SA2 protein expression have been reported in multiple cancer cell lines, including urothelial bladder carcinomas, Ewing’s sarcomas, glioblastomas, and malignant melanomas (21).